{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:49:37Z","timestamp":1790232577528,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.radonc.2015.08.029","type":"journal-article","created":{"date-parts":[[2015,9,20]],"date-time":"2015-09-20T18:54:22Z","timestamp":1442775262000},"page":"178-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up"],"prefix":"10.1016","volume":"117","author":[{"given":"Agn\u00e8s","family":"Ruskon\u00e9-Fourmestraux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Matysiak-Budnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedia","family":"Brixi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Le Malicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Nion-Larmurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fan\u00e7ois","family":"Fl\u00e9jou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Qu\u00e9ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2015.08.029_b0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255","article-title":"Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both?","volume":"87","author":"Savio","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2015.08.029_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/annonc\/8.suppl_2.S37","article-title":"Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies","volume":"8","author":"Montalban","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/gut.48.3.297","article-title":"Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment","volume":"48","author":"Ruskone-Fourmestraux","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gut.53.1.34","article-title":"Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series","volume":"53","author":"Fischbach","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.radonc.2015.08.029_b0030","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","article-title":"Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series","volume":"56","author":"Fischbach","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0035","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-8140(96)01832-4","article-title":"Radiotherapy for treatment of localized gastrointestinal non-Hodgkin\u2019s lymphoma","volume":"42","author":"Kocher","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/annonc\/8.suppl_1.S85","article-title":"Primary lymphoma of the stomach: three-year results of a prospective multicenter study. The German Multicenter Study Group on GI-NHL","volume":"8","author":"Koch","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0050","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdn668","article-title":"Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy","volume":"20","author":"Gobbi","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0055","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0360-3016(99)00475-7","article-title":"Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study","volume":"46","author":"Willich","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.029_b0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0065","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3349\/ymj.2002.43.5.601","article-title":"Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone","volume":"43","author":"Park","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.radonc.2015.08.029_b0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2008.03.012","article-title":"Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study","volume":"87","author":"Yamashita","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","article-title":"Long-term results of stomach-conserving therapy in gastric MALT lymphoma","volume":"87","author":"Vrieling","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0090","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.08.029_b0095","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"229","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.radonc.2015.08.029_b0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/gut.52.6.912","article-title":"Paris staging system for primary gastrointestinal lymphomas","volume":"52","author":"Ruskone-Fourmestraux","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.029_b0115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2015.08.029_b0120","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/gast.2002.33047","article-title":"T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication","volume":"122","author":"Liu","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.radonc.2015.08.029_b0125","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.24605","article-title":"Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type","volume":"115","author":"Salar","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2015.08.029_b0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/10428190903431820","article-title":"Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up","volume":"51","author":"Levy","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.radonc.2015.08.029_b0135","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis","author":"Zullo","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0140","doi-asserted-by":"crossref","first-page":"ii70","DOI":"10.1093\/annonc\/mdn094","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"19","author":"Zucca","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1042819021000035680","article-title":"Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976\u20132001","volume":"44","author":"Thieblemont","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.radonc.2015.08.029_b0150","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"Wundisch","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ijrobp.2003.09.002","article-title":"Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma","volume":"58","author":"Park","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.029_b0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jnci\/djq069","article-title":"Re: late effects from radiation therapy: the hits just keep on coming","volume":"102","author":"Aleman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2015.08.029_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2014.08.039","article-title":"IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer","volume":"112","author":"Trip","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2014.11.046","article-title":"Passive breath gating equipment for cone beam CT-guided RapidArc gastric cancer treatments","volume":"114","author":"Hu","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2015.08.029_b0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.radonc.2007.12.018","article-title":"Intrafractional gastric motion and interfractional stomach deformity during radiation therapy","volume":"87","author":"Watanabe","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0185","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.ejca.2008.07.005","article-title":"Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study","volume":"44","author":"Capelle","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2015.08.029_b0190","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdi242","article-title":"Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?","volume":"16","author":"Copie-Bergman","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2015.08.029_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4143\/crt.2014.46.1.33","article-title":"The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma","volume":"46","author":"Nam","year":"2014","journal-title":"Cancer Res Treat"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814015004545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T14:09:15Z","timestamp":1599574155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814015004545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0167814015004545"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.029","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2015.08.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}